Ameliorating effects of Lactobacillus probiotics on cadmium-induced hepatotoxicity, inflammation, and oxidative stress in Wistar rats

被引:0
作者
Kohan A. [1 ]
Keshtmand Z. [1 ]
机构
[1] Departmant of Biology, Central Tehran Branch, Islamic Azad University, Tehran
关键词
Anti-inflammatory agents; Antioxidants; Cadmium chloride; Liver; Probiotic;
D O I
10.1007/s00580-024-03583-5
中图分类号
学科分类号
摘要
Cadmium (Cd) causes significant oxidative stress, which can lead to major clinical complications and tissue destruction. In this study, the antioxidant and anti-inflammatory effects of a mixture of Iranian probiotic strains were evaluated in Cd-exposed rats. Twenty-one adult male Wistar rats were randomized into three groups of seven rats: the control group, Cd-treated (3 mg/kg, a single dose) animals, and the rats treated with Cd + probiotic (Cd + Pro) for 30 days. Histological changes were assessed using hematoxylin and eosin staining, as well as Masson’s trachoma staining. The qRT-PCR method was used for evaluating pro-inflammatory genes’ expression. Liver biomarkers (ALT, ALP, and AST), biochemical enzymes, and blood parameters were measured using commercial kits, and hematological parameters were determined in both Cd- and the Cd + Pro–treated groups. Histopathologically, results revealed that the native probiotic mixture improved the function of Cd-treated liver cells, compared with Cd-treated rats. Also, positive changes of blood parameters and liver biomarker were observed in the treated group compared with the Cd-treated group. There was a down-regulation of TNF-α and IL-6 genes’ expression in Cd + Pro–treated compared with the Cd-treated group. In addition, Cd + Pro–treated rats displayed lower production of lipid peroxides, lower levels of hepatic toxicity biomarkers, and increased levels of CAT and SOD antioxidant biomarkers compared to Cd-treated animals. Iranian native probiotics showed antioxidant and anti-inflammatory properties, and it is suggested to investigate their health benefits in animal studies in the future. © The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature 2024.
引用
收藏
页码:653 / 664
页数:11
相关论文
共 69 条
  • [1] Ahmad M.N., Mokhtar M.N., Baharuddin A.S., Et al., Changes physicochemical and microbial community during co-composting of oil palm frond, BioResource, 6, pp. 4762-4780, (2011)
  • [2] Akesson A., Bjellerup P., Lundh T., Et al., Cadmium-induced effects on bone in a population-based study of women, Environ Health Perspect, 114, pp. 830-834, (2006)
  • [3] Akhmadeeva K., Belova A., Karimova R., Biochemical parameters of rat blood in the models of chronic heart failure and chronic kidney disease at the administration of nitric oxide donor, BIO Web Conf, 27, (2020)
  • [4] Al-Baqami N.M., Hamza R.Z., Protective effect of resveratrol against hepatotoxicity of cadmium in male rats: antioxidant and histopathological approaches, Coatings, (2021)
  • [5] Alexander J., Benford D., Boobis A., Et al., Marine biotoxins in shellfish – domoic acid scientific opinion of the Panel on Contaminants in the Food Chain Adopted on 2 July 2009, EFSA J, 1181, pp. 1-61, (2009)
  • [6] Aliahmat N.S., Noor M.R.M., Yusof W.J.W., Et al., Antioxidant enzyme activity and malondialdehyde levels can be modulated by Piper betle, tocotrienol rich fraction and Chlorella vulgaris in aging C57BL/6 mice, Clinics, 67, pp. 1447-1454, (2012)
  • [7] Al-Nasser I.A., Cadmium hepatotoxicity and alterations of the mitochondrial function, J Toxicol Clin Toxicol, 38, pp. 407-413, (2000)
  • [8] Arroyo V.S., Flores K.M., Ortiz L.B., Et al., Liver and cadmium toxicity, J Drug Metab Toxicol, (2013)
  • [9] Bagchi D., Bagchi M., Hassoun E.A., Stohs S.J., Cadmium-induced excretion of urinary lipid metabolites, DNA damage, glutathione depletion, and hepatic lipid peroxidation in Sprague-Dawley rats, Biol Trace Elem Res, 52, pp. 143-154, (1996)
  • [10] Behrouz V., Aryaeian N., Jazayeri S., Effects of probiotic and prebiotic supplementation on metabolic parameters, liver aminotransferases, And Systemic Inflammation in Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial, (2021)